AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 48.78 |
Market Cap | 60.45B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 3.94 |
PE Ratio (ttm) | 12.19 |
Forward PE | n/a |
Analyst | Buy |
Ask | 48.85 |
Volume | 14,435,111 |
Avg. Volume (20D) | 13,723,800 |
Open | 46.42 |
Previous Close | 46.01 |
Day's Range | 46.34 - 48.09 |
52-Week Range | 43.56 - 80.75 |
Beta | undefined |
About CVS
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment of...
Analyst Forecast
According to 17 analyst ratings, the average rating for CVS stock is "Buy." The 12-month stock price forecast is $66, which is an increase of 37.40% from the latest price.
Next Earnings Release
Analysts project revenue of $97.13B, reflecting a 3.54% YoY growth and earnings per share of 1.05, making a -50.47% decrease YoY.
Past Earnings Volatility
3 weeks ago · youtube.com
Cramer's Mad Dash: CVS HealthCNBC's Jim Cramer delivers his daily Mad Dash.
3 weeks ago · proactiveinvestors.com
CVS contributing to US opioid crisis, Justice Department allegesCVS Health Corp (NYSE:CVS) has been accused by the US Department of Justice of violating the Controlled Substances Act (CSA) and the False Claims Act (FCA). A lawsuit filed in Rhode Island claims CVS ...
3 weeks ago · https://thefly.com
Barclays fact-checked Trump comments on pharmacy benefit managersBarclays analyst Andrew Mok said that while the existential risk to pharmacy benefit managers is low, President-elect Trump's comments yesterday point to additional headline risk and greater support f...